Immediate Impact
1 from Science/Nature 56 standout
Citing Papers
Advances in cancer immunotherapy: historical perspectives, current developments, and future directions
2025 Standout
TET (Ten-eleven translocation) family proteins: structure, biological functions and applications
2023 Standout
Works of Bernhard J. Woermann being referenced
Genetic heterogeneity of cytogenetically normal AML with mutations of CEBPA
2018
The addition of rituximab to front-line therapy with CHOP (R-CHOP) results in a higher response rate and longer time to treatment failure in patients with lymphoplasmacytic lymphoma: results of a randomized trial of the German Low-Grade Lymphoma Study Group (GLSG)
2008
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Bernhard J. Woermann | 324 | 174 | 210 | 21 | 462 | |
| Nils Winkelmann | 276 | 234 | 285 | 18 | 553 | |
| Kristina Vermaelen | 408 | 173 | 194 | 15 | 538 | |
| Eva Arranz | 247 | 163 | 167 | 24 | 537 | |
| Patricia Martin‐Regueira | 318 | 103 | 197 | 20 | 444 | |
| Koorosh Korfi | 237 | 219 | 148 | 17 | 526 | |
| Dominique Mühlematter | 359 | 209 | 157 | 25 | 520 | |
| RT Silver | 344 | 148 | 277 | 13 | 575 | |
| J. W. G. Janssen | 269 | 233 | 126 | 18 | 549 | |
| JM Hernández | 343 | 184 | 100 | 12 | 423 | |
| Gerlinde Mitterbauer‐Hohendanner | 320 | 85 | 211 | 20 | 516 |
All Works
Loading papers...